EP2345425

LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP11162751A
Filing Date
Dec 26, 2006
Status
Revoked
Jun 25, 2021
Grant Date
Jul 11, 2018
External Links
Slate, Register

Biblio Summary

The patent EP2345425B1 was granted on Jul 11, 2018 by Laboratoire Français Du Fractionnement Et Des Biotechnologies The patent is currently Revoked.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

OCTAPHARMA AGApr 11, 2019ADMISSIBLE
TAKEDA PHARMACEUTICALS INTERNATIONAL AGApr 11, 2019ADMISSIBLE

The table below shows the patents of Laboratoire Français Du Fractionnement Et Des Biotechnologies that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3481415Stable Liquid FibrinogenSep 6, 20233
EP3806891Combination Of Factor Vii And An Anti-Factor Ix/X Bispecific AntibodyAug 2, 20231
EP2651978Use Of An Antibody Directed Against A Membrane ProteinJan 12, 20221

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.